CTOs on the Move

IPS Research Company

www.ipsresearch.com

 
IPS Research Company is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oklahoma City, OK. To find more information about IPS Research Company, please visit www.ipsresearch.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.ipsresearch.com
  • 1111 N Lee Ave Ste 400
    Oklahoma City, OK USA 73103-2620
  • Phone: 405.235.8188

Executives

Name Title Contact Details

Similar Companies

Evanston Regional Hospital

Evanston Regional Hospital is your community healthcare provider; a 42-bed facility with complete inpatient and outpatient care. We believe in the power of people to create great care. We`re more than 50 healthcare professionals strong. We are a Joint Commission accredited facility. And we work hard every day to be a place of healing, caring and connection for patients and families in the community we call home.

Holy Redeemer Health System

Holy Redeemer Health System is committed to our mission to care, comfort and heal, and to providing excellent healthcare services to our community.

AOR Canada Advanced Orthomolecular Research Inc

AOR Canada Advanced Orthomolecular Research Inc is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Freedom Health

Freedom Health, Inc. is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.